Genetic cardiovascular risk factors and age-related macular degeneration

Acta Ophthalmologica

Volumn 89, Issue 4, 2011, Pages 335-338

  Haas, Paulina ^a   Aggermann, Tina ^a   Steindl, Kerstin ^a   Krugluger, Walter ^b   Pühringer, Helene ^c   Oberkanins, Christian ^c   Frantal, Sophie ^d   Binder, Susanne ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b Institute of Medical Laboratory   (Austria)

^c VIENNALAB DIAGNOSTICS GMBH   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

age related macular degeneration; cardiovascular risk factors; genetics

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; APOLIPOPROTEIN B; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIAL PROTEIN C RECEPTOR; FIBRINOGEN; FIBRINOGEN B BETA CHAIN; GLYCINE; HUMAN PLATELET ANTIGEN 1; LEUCINE; LYMPHOTOXIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG; VALINE;

ACE GENE; ADULT; AGED; APOB GENE; APOE GENE; ARTICLE; AUSTRIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENOS GENE; EPCR GENE; FEMALE; FV GENE; FXIII GENE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HPA1 GENE; HUMAN; LTA GENE; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; PAI 1 GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN GENE; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRINOGEN; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SINGLE-BLIND METHOD;

EID: 79958078776     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01697.x     Document Type: Article

References (25)

1. Age-related Eye Disease Study Research Group (2001): The Age-related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 132: 668-681.
2. Ambatti J, (2003): Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48: 257-293.
3. Braun A, Müller B, &, Rosche AA, (1996): Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C. Hum Genet 97: 263-264. (Pubitemid 26034799)
4. Chylack LT Jr, Wolfe JK, Singer DM, et al., (1993): The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 111: 831-836.
5. Cooke GE, Doshi A, &, Binkley PF, (2007): Endothelial nitric oxide synthase gene: prospects for treatment of heart disease. Pharmacogenomics 8: 1723-1734.
6. Dedoussis GV, (2007): Apolipoprotein polymorphisms and familial hypercholesterolemia. Pharmacogenomics 8: 1179-1189. (Pubitemid 47578227)
7. Friedman E, (2000): The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 130: 658-663.
8. Fritsche LG, Freitag-Wolf S, Bettecken T, et al., (2009): Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene. Hum Mutat. 30: 1048-1053.
9. Gemmati D, Federici F, Campo G, et al., (2007): Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. Mol Med 13: 112-120. (Pubitemid 46786840)
10. Grunwald JE, Hariprasad SM, DuPont J, et al., (1998): Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 39: 385-390. (Pubitemid 28093877)
11. Helgadottir A, Thorleifsson G, Magnusson KP, et al., (2008): The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 40: 217-224. (Pubitemid 351171400)
12. Klein R, Deng Y, Klein BE, et al., (2007): Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol 143: 473-483.
13. Lijnen HR, (2005): Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 3: 35-45. (Pubitemid 41647113)
14. Lip GY, (1995): Fibrinogen and cardiovascular disorders. QJM 88: 155-165.
15. Lunghi B, Iacoviello L, Gemmati D, et al., (1996): Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost 75: 45-48. (Pubitemid 26051193)
16. Medina P, Navarro S, Estellés A, et al., (2005): Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden. Thromb Haemost 94: 389-394. (Pubitemid 41122494)
17. Muthumala A, Montgomery H, Palmen J, Cooper JA, &, Humphries SE, (2007): Angiotensin-converting enzyme genotype interacts with systolic blood pressure to determine coronary heart disease risk in healthy middle-aged men. Hypertension 50: 348-353. (Pubitemid 47205784)
18. Real JT, Chaves FJ, Ejarque I, et al., (2003): Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population. Eur J Hum Genet 11: 959-965. (Pubitemid 38072163)
19. Seitsonen S, Järvelä I, Meri S, Tommila P, Ranta P, &, Immonen I, (2008): Complement factor H Y402H polymorphism and characteristics of exudative age-related macular degeneration lesions. Acta Ophthalmol 86: 390-394.
20. Sofi F, Lari B, Rogolino A, et al., (2005): Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg 41: 255-260. (Pubitemid 40342476)
21. Tan JS, Mitchell P, Smith W, &, Wang JJ, (2007): Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 114: 1143-1150. (Pubitemid 46829381)
22. Topol EJ, Smith J, Plow EF, &, Wang QK, (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet. 15 (Suppl 2): R117-R123. (Pubitemid 44446784)
23. Utheim OA, Ritland JS, Utheim TP, et al., (2008): Apolipoprotein E genotype and risk for development of cataract and age-related macular degeneration. Acta Ophthalmol 86: 401-403.
24. Varga EA, &, Moll S, (2004): Cardiology patient pages. Prothrombin 20210 mutation (factor II mutation). Circulation 110: e15-e18.
25. Vine AK, Stader J, Branham K, Musch DC, &, Swaroop A, (2005): Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 112: 2076-2080. (Pubitemid 41720983)